BioRestorative Therapies, Inc. Share Price Other OTC
Stocks
BRTX
US0906554086
Biotechnology & Medical Research
| Market Cap | 51.98L 44.96L 41.98L 38.51L 72.44L 49Cr 73.59L 4.93Cr 1.93Cr 25Cr 1.95Cr 1.91Cr 82Cr | P/E 2026 * |
-0.41x | P/E 2027 * | -0.5x |
|---|---|---|---|---|---|
| Enterprise Value | 51.98L 44.96L 41.98L 38.51L 72.44L 49Cr 73.59L 4.93Cr 1.93Cr 25Cr 1.95Cr 1.91Cr 82Cr | EV / Sales 2026 * |
3.7x | EV / Sales 2027 * | 2.25x |
| Free-Float |
89.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioRestorative Therapies, Inc.
| 1 day | +1.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Katharyn Field
CEO | Chief Executive Officer | 32 | 13/07/2026 |
Rory Rumore
IRC | Investor Relations Contact | - | - |
Crystal Romano
PRN | Corporate Officer/Principal | - | 22/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Jay Dhaliwal
BRD | Director/Board Member | 37 | 12/06/2026 |
Esha Randhawa
BRD | Director/Board Member | - | 13/07/2026 |
Mika Grasso
BRD | Director/Board Member | 28 | 12/06/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.08% | +0.25% | - | - | 51.98L | |
| +8.49% | +20.55% | +70.77% | +110.32% | 6.81TCr | |
| +1.25% | +2.44% | +34.27% | +70.43% | 5.52TCr | |
| -1.09% | +32.96% | +19.67% | +494.56% | 2.86TCr | |
| +10.83% | +18.38% | +56.20% | +6.03% | 2.4TCr | |
| +2.72% | +3.41% | -16.11% | -7.96% | 2.35TCr | |
| +6.50% | +7.56% | +44.65% | -21.73% | 1.84TCr | |
| +6.20% | +11.51% | +33.87% | +693.38% | 1.64TCr | |
| -3.88% | +16.98% | +199.30% | +359.77% | 1.58TCr | |
| +3.58% | +1.96% | +43.35% | +163.76% | 1.34TCr | |
| Average | +3.57% | +11.68% | +54.00% | +207.62% | 2.93TCr | |
| Weighted average by Cap. | +4.36% | +13.10% | +50.69% | +168.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.05L 12.15L 11.35L 10.41L 19.58L 13Cr 19.89L 1.33Cr 52.26L 6.7Cr 52.76L 51.61L 22Cr | 23.12L 20L 18.68L 17.14L 32.23L 22Cr 32.74L 2.19Cr 86.02L 11Cr 86.84L 84.94L 36Cr |
| Net income | -1.35Cr -1.17Cr -1.09Cr -1Cr -1.88Cr -128.71Cr -1.91Cr -13Cr -5.03Cr -65Cr -5.08Cr -4.97Cr -213.27Cr | -1.56Cr -1.35Cr -1.26Cr -1.15Cr -2.17Cr -148.07Cr -2.2Cr -15Cr -5.79Cr -74Cr -5.84Cr -5.71Cr -245.36Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
